A61K 51/1084
The antibody being a hybrid immunoglobulin
Official title: {the antibody being a hybrid immunoglobulin}
A61K51/1084 (The antibody being a hybrid immunoglobulin) appears on 107 US grants and 124 published applications in this corpus.
Search patents in A61K- Granted patents
- 107
- Published applications
- 124
- Assignees
- 54
- Inventors
- 216
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 6 | 0 |
| 1996 | 1 | 0 |
| 1997 | 6 | 0 |
| 1998 | 1 | 0 |
| 1999 | 4 | 0 |
| 2000 | 3 | 0 |
| 2001 | 3 | 0 |
| 2002 | 4 | 4 |
| 2003 | 4 | 4 |
| 2004 | 1 | 6 |
| 2005 | 0 | 3 |
| 2006 | 3 | 4 |
| 2007 | 1 | 1 |
| 2008 | 2 | 6 |
| 2009 | 4 | 11 |
| 2010 | 2 | 2 |
| 2011 | 2 | 6 |
| 2012 | 7 | 6 |
| 2013 | 10 | 7 |
| 2014 | 6 | 9 |
| 2015 | 8 | 6 |
| 2016 | 5 | 5 |
| 2017 | 2 | 3 |
| 2018 | 0 | 2 |
| 2019 | 1 | 1 |
| 2020 | 0 | 6 |
| 2021 | 1 | 3 |
| 2022 | 3 | 4 |
| 2023 | 3 | 6 |
| 2024 | 3 | 6 |
| 2025 | 5 | 5 |
| 2026 | 1 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Meditopes and meditope-binding antibodies and uses thereof25 Aug 2026US 12,714,753 B2City of Hope
- Hybrid immunoglobulins with moving parts11 Nov 2025US 12,467,053 B2Biomolecular Holdings LLC
- Cysteine linked nanobody dimers12 Aug 2025US 12,384,835 B2Ablynx N. V.
- Modular self assembly disassembly (SADA) technologies1 Jul 2025US 12,343,401 B2Memorial Sloan Kettering Cancer Center
- Antibody-drug conjugates and uses thereof27 May 2025US 12,310,958 B2Immunomedics, Inc.
- Multifunctional antibodies10 Sep 2026US 2026/0263645 A1Telix Pharmaceuticals (Innovations) Pty Ltd.
- Bispecific antibody compounds18 Jun 2026US 2026/0166185 A1Y-Mabs Therapeutics, Inc.
- Multivalent immunoconjugates for targeted radioisotope therapy21 May 2026US 2026/0137822 A1Abdera Therapeutics Inc.
- Vhh antibodies and uses thereof30 Apr 2026US 2026/0116990 A1Key2Brain AB
- Kidney targeting antibodies26 Feb 2026US 2026/0055180 A1Abdera Therapeutics Inc.
Most cited
By later US patents
- Antibody conjugates reactive with human carcinomas196US 5,869,045 ABristol-Myers Squibb Company · 1999
- Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype98US 5,698,178 AImmunomedics, Inc. · 1997
- Prostaglandin E2 dual variable domain immunoglobulins and uses thereof85US 8,822,645 B2AbbVie Inc. · 2014
- Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins80US 7,534,427 B2Immunomedics, Inc. · 2009
- Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same71US 5,474,771 AThe Trustees of Columbia University in the City of New York · 1995